Call your doctor before leaving home if you think you’ve been exposed to COVID-19 or have symptoms

Due to the presence of COVID-19 in our community, visitor restrictions are in place for all Duke clinics and hospitals. For your safety and the safety of others, we recommend patients do not bring a visitor to Duke clinics, if at all possible. If a visitor must accompany a patient, only one individual over 12 years of age is allowed. Patients and visitors will be screened for symptoms upon arrival. Individuals with flu-like symptoms are not allowed. View the complete list of Visitor Restrictions.

Effective immediately, Duke Health is prioritizing and rescheduling some non-emergent or non-critical surgeries, procedures, and appointments. Check our COVID-19 (Coronavirus) page for updates.

Hand transplantation - Clinical Trial

What is the Purpose of this Study?

We are doing this study to understand how hand transplantation can help you with your daily activities compared to before the transplant.
What is the Condition Being Studied?
Hand Transplantation

Who Can Participate in the Study?

- Adults 18 - 60
- One or both limb loss

Age Group
Adults

What is Involved?

If you choose to join this study you will:
- Have a hand transplant
- Take the study drug, Nulojix (a drug that is used in other transplants to help stop your body from rejecting the hand)
- Complete follow-up visits for 18 months after the surgery, and at least once a year after surgery
- Get blood drawn
- Have biopsies
- Complete questionnaires
- Have x-rays/CT pictures of your hand

Study Details

Full Title
Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy
Principal Investigator
Protocol Number
IRB: PRO00056079
NCT: NCT02310867
Phase
Phase II
ClinicalTrials.gov
Contact the Duke Recruitment Innovation Center
MyResearchPartners@duke.edu
or
919-681-5698